Advances in Pharma Business Management and Research (Record no. 552181)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04557nam a22006375i 4500 |
001 - | |
control field | 978-3-030-35918-8 |
003 - | |
control field | DE-He213 |
005 - | |
control field | 20211012180217.0 |
007 - | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200219s2020 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9783030359188 |
-- | 978-3-030-35918-8 |
024 7# - | |
-- | 10.1007/978-3-030-35918-8 |
-- | doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
-- | RS380 |
-- | RS190-210 |
072 #7 - | |
-- | TDCW |
-- | bicssc |
-- | MED072000 |
-- | bisacsh |
-- | TDC |
-- | thema |
082 04 - | |
Classification number | 615.19 |
-- | 23 |
245 10 - TITLE STATEMENT | |
Title | Advances in Pharma Business Management and Research |
Remainder of title | Volume 1 / |
Statement of responsibility, etc | edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. 2020. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | X, 85 p. 11 illus. |
Other physical details | online resource. |
505 0# - | |
Formatted contents note | Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
650 #0 - | |
Topical term or geographic name as entry element | Pharmaceutical technology. |
Topical term or geographic name as entry element | Health care management. |
Topical term or geographic name as entry element | Health services administration. |
Topical term or geographic name as entry element | Medical laws and legislation. |
Topical term or geographic name as entry element | Pharmacy. |
Topical term or geographic name as entry element | Pharmacy management. |
Topical term or geographic name as entry element | Pharmaceutical Sciences/Technology. |
Topical term or geographic name as entry element | Health Care Management. |
Topical term or geographic name as entry element | Medical Law. |
Topical term or geographic name as entry element | Pharmacy. |
Topical term or geographic name as entry element | Pharmacoeconomics and Health Outcomes. |
700 1# - | |
Personal name | Schweizer, Lars. |
Relator term | editor. |
Personal name | Dingermann, Theodor. |
Relator term | editor. |
Personal name | Russe, Otto Quintus. |
Relator term | editor. |
Personal name | Jansen, Christian. |
Relator term | editor. |
710 2# - | |
Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
856 40 - | |
Uniform Resource Identifier | https://doi.org/10.1007/978-3-030-35918-8 |
245 10 - TITLE STATEMENT | |
-- | [electronic resource] : |
264 #1 - | |
-- | Cham : |
-- | Springer International Publishing : |
-- | Imprint: Springer, |
-- | 2020. |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
506 0# - | |
-- | Open Access |
520 ## - | |
-- | This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. |
-- | https://scigraph.springernature.com/ontologies/product-market-codes/B21010 |
-- | https://scigraph.springernature.com/ontologies/product-market-codes/527030 |
-- | https://scigraph.springernature.com/ontologies/product-market-codes/R16005 |
-- | https://scigraph.springernature.com/ontologies/product-market-codes/F00008 |
-- | https://scigraph.springernature.com/ontologies/product-market-codes/H69020 |
700 1# - | |
-- | edt |
-- | http://id.loc.gov/vocabulary/relators/edt |
-- | edt |
-- | http://id.loc.gov/vocabulary/relators/edt |
-- | edt |
-- | http://id.loc.gov/vocabulary/relators/edt |
-- | edt |
-- | http://id.loc.gov/vocabulary/relators/edt |
773 0# - | |
-- | Springer Nature eBook |
776 08 - | |
-- | Printed edition: |
-- | 9783030359171 |
-- | Printed edition: |
-- | 9783030359195 |
-- | Printed edition: |
-- | 9783030359201 |
912 ## - | |
-- | ZDB-2-SBL |
-- | ZDB-2-SXB |
-- | ZDB-2-SOB |
950 ## - | |
-- | Biomedical and Life Sciences (SpringerNature-11642) |
-- | Biomedical and Life Sciences (R0) (SpringerNature-43708) |
No items available.